Institut Curie
Clinical trials sponsored by Institut Curie, explained in plain language.
-
Immunotherapy combo shows promise in cervical cancer trial
Disease control CompletedThis early-phase study tested adding the immunotherapy drug nivolumab to standard chemoradiation for people with locally advanced cervical cancer. The main goal was to check safety and find the right dose, while also looking at how well the combination worked. 21 adults took part…
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 17, 2026 11:54 UTC
-
New scan-guided radiation shows promise for rare bone cancer
Disease control CompletedThis study tested whether adding a special PET scan (FAZA PET/CT) to standard imaging can improve local control of chordoma, a rare bone tumor, after surgery. The scan identifies oxygen-starved (hypoxic) cells that are resistant to radiation, allowing doctors to target them more …
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 17, 2026 11:53 UTC
-
New chemo combo shows promise for Tough-to-Treat ewing sarcoma
Disease control CompletedThis study tested a more intense chemotherapy plan for people aged 2 to 50 with Ewing sarcoma that has spread to bones or bone marrow. The goal was to see if the stronger treatment could improve how long patients live without the cancer getting worse. 45 patients took part, and t…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Radiation showdown: which schedule beats childhood brain cancer?
Disease control CompletedThis study tested two different ways of giving radiation to children and teens (ages 4 to 21) with a standard-risk brain tumor called medulloblastoma. One method used smaller, more frequent doses (hyperfractionated), while the other used standard daily doses. The goal was to see …
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Cervical cancer trial: does adding cetuximab to Chemo-Radiation help?
Disease control CompletedThis study tested whether adding a targeted drug called cetuximab to standard radiation and chemotherapy (cisplatin) could help control cervical cancer better than standard treatment alone. It involved 76 patients with stage IB2 to IIIB cervical cancer that was not immediately op…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Spinal fluid drug shows promise for rare breast cancer complication
Disease control CompletedThis study tested the drug trastuzumab, given directly into the spinal fluid, for people with HER2-positive breast cancer that spread to the lining of the brain (carcinomatous meningitis). The goal was to find a safe dose and see if it could slow the cancer's growth in the nervou…
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Promising combo for tough breast cancer passes early safety test
Disease control CompletedThis early-phase study tested the drug olaparib together with radiation in 24 women with advanced triple-negative breast cancer that did not respond to chemotherapy. The main goal was to find the safest dose of olaparib when used with radiation. The study is complete, and results…
Phase: PHASE1 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New combo offers hope for myeloma patients who relapsed after first treatment
Disease control CompletedThis study tested a combination of three drugs (pomalidomide, cyclophosphamide, and dexamethasone) in 100 adults with multiple myeloma whose cancer returned after initial treatment. Participants had previously received standard therapies including bortezomib and lenalidomide. The…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Blood test could unlock targeted therapy for women with hard-to-treat breast cancer
Disease control CompletedThis study looked at 155 women with metastatic breast cancer whose original tumors were HER2-negative. Researchers checked their blood for HER2-amplified circulating tumor cells. If found, participants received the drug T-DM1. The goal was to see if these blood-based markers coul…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Quick PSA test shows promise for prostate cancer screening
Diagnosis CompletedThis study tested a new, rapid PSA test that uses a small drop of blood to quickly screen for prostate cancer. Researchers compared its accuracy to the standard lab test in 94 patients with prostate issues. The goal was to see if the faster test could reliably detect high PSA lev…
Phase: NA • Sponsor: Institut Curie • Aim: Diagnosis
Last updated May 17, 2026 11:56 UTC
-
Numbing shot may stop chronic pain after breast cancer surgery
Prevention CompletedThis study tested whether injecting a local anesthetic (ropivacaine) during breast cancer surgery could prevent chronic pain that often follows. 260 women having breast-conserving surgery or mastectomy received either the anesthetic or a placebo. The main goal was to see if fewer…
Phase: PHASE4 • Sponsor: Institut Curie • Aim: Prevention
Last updated May 17, 2026 11:56 UTC
-
Early support may ease mental burden of advanced eye cancer
Symptom relief CompletedThis study looked at whether adding supportive care early on helps with the emotional and practical needs of people with metastatic uveal melanoma, a rare eye cancer that has spread. 162 adults took part, filling out surveys about their care needs after 6 months. The goal was to …
Phase: NA • Sponsor: Institut Curie • Aim: Symptom relief
Last updated May 17, 2026 11:55 UTC
-
Day hospital aims to ease life for advanced cancer patients
Symptom relief CompletedThis study looked at whether a day hospital focused on integrated palliative care can improve quality of life for adults with advanced cancer. 144 patients took part. The goal was to see if this approach helps patients feel better and supports their caregivers.
Phase: NA • Sponsor: Institut Curie • Aim: Symptom relief
Last updated May 17, 2026 11:54 UTC
-
Which nerve block cuts Post-Surgery morphine use?
Symptom relief CompletedThis study compared two types of nerve blocks (ESP and PVB) given before breast cancer surgery to see which one better controls pain right after the operation. About 292 women having breast surgery took part. The main goal was to see how many patients needed morphine in the first…
Phase: PHASE4 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated May 11, 2026 20:54 UTC
-
New dressing may prevent radiation treatment delays for breast cancer patients
Symptom relief CompletedThis study tested whether a special dressing (Hydrosorb) is better than a water-based spray at managing skin irritation from radiation therapy in 278 women with breast cancer. The goal was to prevent skin damage from getting worse and avoid interruptions in radiation treatment. P…
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated May 11, 2026 20:47 UTC
-
Nerve block may reduce pain after breast surgery
Symptom relief CompletedThis study tested whether a numbing injection (ropivacaine) given near the chest muscles before breast cancer surgery could reduce pain right after the operation. 182 women having a lumpectomy with lymph node removal took part. The goal was to see if fewer patients needed strong …
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
Morphine gel offers hope for severe radiation skin pain
Symptom relief CompletedThis study looked at whether a morphine gel applied to the skin can reduce pain from severe radiation burns (radiodermatitis) in the perineal area. Seventeen patients who were not getting enough relief from standard pain pills were included. The main goal was to see if pain decre…
Sponsor: Institut Curie • Aim: Symptom relief
Last updated May 11, 2026 20:37 UTC
-
Can boosting tumor blood flow make cancer treatment more effective?
Knowledge-focused CompletedThis study tested whether temporarily stopping blood flow to a skin cancer (basal cell carcinoma) and then releasing it could increase blood flow to the tumor. 12 adults with this skin cancer had their tumor's blood supply briefly clamped during surgery. Researchers used a specia…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 17, 2026 12:01 UTC
-
Question booklet boosts communication in End-of-Life cancer care
Knowledge-focused CompletedThis study tested whether giving a booklet with suggested questions helps cancer patients or their families ask more during palliative care visits. 121 adults with metastatic cancer and limited life expectancy took part. The goal was to see if the booklet encourages people to ask…
Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 17, 2026 12:01 UTC
-
New blood test spots cancer DNA in eye melanoma patients
Knowledge-focused CompletedThis study aimed to develop and validate a blood test that can detect circulating tumor DNA in patients with metastatic choroidal melanoma, a rare eye cancer that has spread. Researchers collected blood samples from 40 adult patients and compared different detection techniques (P…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 17, 2026 12:00 UTC
-
Gene-Tailored cancer drugs fail to outperform standard care in large trial
Knowledge-focused CompletedThis study tested whether choosing cancer drugs based on the genetic profile of a patient's tumor could help people with advanced solid tumors live longer without their cancer growing. Over 700 adults whose cancer had stopped responding to standard treatments were randomly assign…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 17, 2026 11:59 UTC
-
Personalized breast cancer risk info: help or worry?
Knowledge-focused CompletedThis study looked at how healthy women with a family history of breast cancer feel after getting a personalized risk estimate using a special computer model. About 405 women took part, and researchers measured their emotional responses and understanding of their risk. The goal wa…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 17, 2026 11:56 UTC
-
Blood test may help decide when to change chemo in advanced breast cancer
Knowledge-focused CompletedThis study looked at whether checking for cancer cells in the blood (circulating tumor cells) can help doctors decide when to switch chemotherapy in women with metastatic breast cancer. 265 women who had already tried two chemotherapies took part. The goal was to see if this appr…
Phase: PHASE3 • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 17, 2026 11:56 UTC
-
Sniffing out cancer: study tests odor sensor for breast cancer detection
Knowledge-focused CompletedThis study tested whether breast cancer has a unique smell that can be detected by a special sensor. Researchers collected odor samples from the hands of 35 women with breast cancer before and after their tumor was removed. The goal was to see if the sensor could identify cancer-…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 17, 2026 11:55 UTC
-
New ultrasound technique may predict chemo success early
Knowledge-focused CompletedThis study tested whether a 3D ultrasound technique called shear wave elastography can accurately predict how breast tumors respond to chemotherapy before surgery. Researchers measured tumor stiffness at several points during treatment in 140 women with locally advanced breast ca…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Healthy Workers' antibodies tracked for a year in COVID-19 study
Knowledge-focused CompletedThis study looked at how long antibodies against the COVID-19 virus last in healthy hospital and non-hospital workers. About 1,971 volunteers from Institut Curie and Institut Pasteur gave blood samples at several time points over a year. The goal was to understand the body's immu…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Scientists peek inside chronic wounds to uncover biofilm secrets
Knowledge-focused CompletedThis study looked at 130 patients with chronic wounds to find out if biofilm (a slimy layer of bacteria) is present and how it affects healing. Researchers used special microscopes and checked medical records. The goal was to learn more, not to test a new treatment.
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Simple urine test could replace needle biopsy for prostate cancer?
Knowledge-focused CompletedThis study collected urine and blood samples from 80 men, including those with prostate cancer, those with suspected cancer, and healthy volunteers. The goal was to find genetic markers (long non-coding RNA) that could help diagnose prostate cancer and predict its progression wit…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
New tool aims to ease tough talks on cancer resistance
Knowledge-focused CompletedThis study aimed to create a communication tool to help doctors and patients talk about cancer that stops responding to treatment. Researchers interviewed 128 people, including patients with certain breast cancers, metastatic uveal melanoma, and parents of children with cancer, a…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC
-
Scientists test new way to spot Cancer-Fighting immune cells in lymph nodes
Knowledge-focused CompletedThis study tested a method to identify immune cells (T cells) that recognize unique mutations in tumors from patients with breast cancer or melanoma. Researchers looked at lymph nodes invaded by cancer to see if these cells were present. The goal was to see if the method works, n…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC
-
Blood test may predict success of liver surgery for rare eye cancer
Knowledge-focused CompletedThis study looked at 60 people with uveal melanoma that spread to the liver and who were eligible for surgery to remove it. Researchers measured circulating tumor DNA in the blood before and after surgery to see if it could predict whether all cancer was removed. The goal was to …
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:15 UTC